Cullinan Therapeutics, Inc. (CGEM)

Last Three Months

18-Feb-24 -- 17-May-24

Time Period:

Three Months
|
Year

0 Net Amount

Buy:	0	--
Sell:	0	--

Company Sentiment

Other

Other

Sentiment Breakdown by Insider

0

(3)

0

(2)

0

(1)

10

0

6

+1

0

+2

0

+3

Two Year Chart

18-May-22 -- 17-May-24

Price ($)

Two Year Stock Price Chart

Sentiment

Buy & Sell Volume ($)

Two Year Insider Trading Volume Chart

Recent Insider Trades

Last Transaction		Last Three Months
SEC Filing	Transaction	Insider	Sentiment	Company	Holdings Change	Buy Amount	Sell Amount	Buy Price Range	Sell Price Range
23-Feb-24 5:00 PM View:	22-Feb-24 Grant 0	Trigilio Jeffrey Chief Financial Officer		Cullinan Therapeutics, Inc. - CGEM	60% 83.92K to 133.92K	0	0	--	--	Show Txns Hide Txns

23-Feb-24 5:00 PM View:	22-Feb-24 Grant 0	Ahmed Nadim President and CEO Director		Cullinan Therapeutics, Inc. - CGEM	143% 111.55K to 271.55K	0	0	--	--	Show Txns Hide Txns

23-Feb-24 5:00 PM View:	22-Feb-24 Grant 0	Jones Jeffrey Alan Chief Medical Officer		Cullinan Therapeutics, Inc. - CGEM	111% 56.19K to 118.69K	0	0	--	--	Show Txns Hide Txns

23-Feb-24 5:00 PM View:	22-Feb-24 Grant 0	Sumer Jacquelyn L Chief Legal Officer		Cullinan Therapeutics, Inc. - CGEM	113% 44.13K to 94.13K	0	0	--	--	Show Txns Hide Txns

23-Feb-24 5:00 PM View:	22-Feb-24 Grant 0	Savill Corrine Chief Business Officer		Cullinan Therapeutics, Inc. - CGEM	23% 165.99K to 203.49K	0	0	--	--	Show Txns Hide Txns

08-May-24 7:30 PM View:	07-May-24 Sale (Planned) ($168.52K)	Michaelson Jennifer Chief Scientific Officer		Cullinan Therapeutics, Inc. - CGEM	48% 87.58K to 129.58K	0	0	--	--	Show Txns Hide Txns